| 注册
首页|期刊导航|医学信息|载吡柔比星微球经导管肝动脉化疗栓塞术联合阿帕替尼在原发性肝癌患者介入治疗中的应用价值

载吡柔比星微球经导管肝动脉化疗栓塞术联合阿帕替尼在原发性肝癌患者介入治疗中的应用价值

何耀强 陈焕伟 杨少苏

医学信息2024,Vol.37Issue(1):125-129,5.
医学信息2024,Vol.37Issue(1):125-129,5.DOI:10.3969/j.issn.1006-1959.2024.01.021

载吡柔比星微球经导管肝动脉化疗栓塞术联合阿帕替尼在原发性肝癌患者介入治疗中的应用价值

Application Value of Transcatheter Arterial Chemoembolization with Pirarubicin-loaded Microspheres Combined with Apatinib Therapy in the Interventional Treatment of Patients with Primary Liver Cancer

何耀强 1陈焕伟 2杨少苏1

作者信息

  • 1. 佛山市第一人民医院影像科,广东 佛山 528000
  • 2. 佛山市第一人民医院肝外科,广东 佛山 528000
  • 折叠

摘要

Abstract

Objective To investigate the effect of transcatheter arterial chemoembolization with pirarubicin-loaded microspheres combined with apatinib orally in the treatment of patients with primary liver cancer.Methods A total of 185 patients who underwent interventional therapy for primary liver cancer in Foshan First People's Hospital from January 2020 to June 2021 were selected as the research objects.According to different treatment methods,they were divided into observation group(93 patients)and control group(92 patients).The observation group was treated with pirarubicin-loaded microsphere TACE combined with apatinib,while the control group was treated with pirarubicin+lipiodol TACE combined with apatinib.The progression-free survival(PFS),overall survival,clinical total effective rate,alpha-fetoprotein(AFP)level and adverse reactions were compared between the two groups.Results The PFS of the observation group was longer than that of the control group(P<0.05).The survival rate of the observation group was higher than that of the control group after 12 months of follow-up,and the differences were statistically significant(P<0.05),but there was no significant difference in the survival rate between the two groups after 6 and 18 months of follow-up(P>0.05).The clinical effective rate and disease control rate of the observation group were higher than those of the control group(P<0.05).After treatment,the AFP level of the two groups was lower than that before treatment,and that of the observation group was lower than that of the control group(P<0.05).The incidence of nausea and vomiting in the observation group was lower than that in the control group(P<0.05),but there was no significant difference in the incidence of pain and fever between the two groups(P>0.05).Conclusion Compared with traditional TACE,transcatheter arterial chemoembolization with pirarubicin-loaded microspheres combined with apatinib is more effective in the treatment of PLC,which can prolong the PFS of patients,improve the survival rate of patients,and at the same time,the gastrointestinal reaction is lighter.

关键词

载吡柔比星微球/经导管肝动脉化疗栓塞术/阿帕替尼/原发性肝癌

Key words

Pirarubicin-loaded microspheres/Transcatheter arterial chemoembolization/Apatinib/Primary liver cancer

分类

医药卫生

引用本文复制引用

何耀强,陈焕伟,杨少苏..载吡柔比星微球经导管肝动脉化疗栓塞术联合阿帕替尼在原发性肝癌患者介入治疗中的应用价值[J].医学信息,2024,37(1):125-129,5.

医学信息

1006-1959

访问量0
|
下载量0
段落导航相关论文